ask="0.7100"
ask_size="7500"
average_daily_volume="4949"
bid="0.0002"
bid_size="N/A"
book_value="0.0000"
change="-0.0467"
change_from_200_day_moving_average="-0.5467"
change_from_50_day_moving_average="-0.2165"
change_from_52_week_high="-1.7167"
change_From_52_week_low="0.0327"
change_in_percent="-20.3043%"
close="0.1833"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="N/A"
ebitda="0.00"
eps_estimate_current_year="N/A"
eps_estimate_next_quarter="0.0000"
eps_estimate_next_year="N/A"
ex_dividend_date="N/A"
float_shares="N/A"
high="0.2200"
high_52_weeks="1.9000"
last_trade_date="3/10/2017"
last_trade_price="0.1833"
last_trade_size="100"
last_trade_time="12:03pm"
low="0.1800"
low_52_weeks="0.1506"
market_capitalization="N/A"
moving_average_200_day="0.7300"
moving_average_50_day="0.3998"
name="Oncobiologics
Inc. - Series B "
notes="N/A"
one_year_target_price="N/A"
open="0.2200"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="-74.8916%"
percent_change_from_50_day_moving_average="-54.1570%"
percent_change_from_52_week_high="-90.3526%"
percent_change_from_52_week_low="+21.7131%"
previous_close="0.2300"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="N/A"
short_ratio="0.0000"
stock_exchange="NGM"
symbol="ONSIZ"
volume="1000"
weeks_range_52="0.1506 - 1.9000"
